EANS-Adhoc: LifeWatch AG
LifeWatch AG´s shares will be included in the SXI
LIFE SCIENCES® and the SXI Bio+Medtech® indices effective as of September 21,
2009
Inclusion in the indices of the SPI® Family remains unchanged
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
Company Information
31.08.2009
Neuhausen am Rheinfall / Switzerland, August 31, 2009 - LifeWatch AG (SIX Swiss Exchange: LIFE), the leading provider of wireless cardiac monitoring services
in the U.S., announces today that according to SIX Swiss Exchange's notification the LifeWatch shares will be included in the SXI LIFE SCIENCES and the SXI Bio+Medtech indices effective as of September 21, 2009. Inclusion in the indices of the SPI Family remains unchanged.
The SXI Indices Family comprises industry sectors that are of particular significance to the Swiss economy; SXI stands for SIX Special Industry. The SXI sector index family was launched in 2004 with the purpose to increase the liquidity of shares listed on SIX Swiss Exchange that belong to internationally significant industries
The SXI LIFE SCIENCES and SXI Bio+Medtech indices reflect the life sciences industry, one of Switzerland's most prominent sectors. The weighting of each individual stock is capped at 10% giving small and medium-sized companies a greater impact. The shares of LifeWatch AG fulfil the following inclusion criteria:
Minimum capitalization The SXI indices only include securities with a free float capitalization of at least CHF 100 million. Capitalization is calculated on the basis of current information regarding the free float of securities available on the benchmark date (July 31, 2009). To qualify for inclusion, the capitalization must at least amount to CHF 100 million on such a benchmark date and, in addition, the average capitalization during 20 trading days preceding the benchmark date must also amount to at least CHF 100 million.
ICB sector classification Sector allocation is based on the ICB (Industry Classification Benchmark) classification standard developed by Dow Jones and the FTSE. The security universe of the two SXI indices encompasses one or more ICB sub-sectors. The respective sub-sectors are: 4533 Medical Providers / 4535 Medical Equipment/ 4537 Medical Supplies / 4573 Biotechnology / 4577 Pharmaceuticals.
Free float In order to be included in one of the SXI indices, the minimum free float of the total shares of a given company must at least be 20%.
LifeWatch AG meets all the above mentioned criteria and its shares will now be included in the two SXI indices effective as of September 21, 2009.
About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless cardiac monitoring services. LifeWatch services treat high-risk and chronically ill patients, health conscious consumers and wellness programs. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products. www.lifewatch.com
Sign-up for customized e-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.
Press Release
August 31, 2009
end of announcement euro adhoc
Further inquiry note:
Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | E-mail kobibe@lifewatch.com
Sensus Investor & Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.c
Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade